| Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs) E Podaza, F Sabbione, D Risnik, M Borge, MB Almejún, A Colado, ... Cancer Immunology, Immunotherapy 66, 77-89, 2017 | 59 | 2017 |
| Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis A Colado, M Genoula, C Cougoule, JL Marín Franco, MB Almejún, ... Blood Cancer Journal 8 (11), 100, 2018 | 32 | 2018 |
| Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis R Fletcher, J Tong, D Risnik, BJ Leibowitz, YJ Wang, ... Oncogene 40 (11), 2035-2050, 2021 | 24 | 2021 |
| The effect of ibrutinib on neutrophil and γδ T cell functions D Risnik, EE Elías, I Keitelman, A Colado, E Podaza, G Cordini, ... Leukemia & Lymphoma 61 (10), 2409-2418, 2020 | 20 | 2020 |
| Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16highCD62Ldim immunosuppressive subset E Podaza, D Risnik, A Colado, E Elías, MB Almejún, H Fernandez Grecco, ... International Journal of Cancer 144 (5), 1128-1134, 2019 | 19 | 2019 |
| Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies EE Elías, MB Almejún, A Colado, G Cordini, M Vergara-Rubio, E Podaza, ... Haematologica 103 (10), e458, 2018 | 19 | 2018 |
| Revisiting the role of interleukin-8 in chronic lymphocytic leukemia D Risnik, E Podaza, MB Almejún, A Colado, EE Elías, RF Bezares, ... Scientific Reports 7 (1), 15714, 2017 | 18 | 2017 |
| BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade J Tong, X Tan, D Risnik, M Gao, X Song, K Ermine, L Shen, S Wang, J Yu, ... Oncogene 40 (48), 6566-6578, 2021 | 15 | 2021 |
| Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer S Hao, J Tong, A Jha, D Risnik, D Lizardo, X Lu, A Goel, PL Opresko, J Yu, ... Proceedings of the National Academy of Sciences 119 (51), e2211775119, 2022 | 14 | 2022 |
| The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients A Colado, MB Almejún, E Podaza, D Risnik, C Stanganelli, EE Elías, ... Cancer Immunology, Immunotherapy 66, 461-473, 2017 | 13 | 2017 |
| CDK4/6 inhibition suppresses p73 phosphorylation and activates DR5 to potentiate chemotherapy and immune checkpoint blockade J Tong, X Tan, X Song, M Gao, D Risnik, S Hao, K Ermine, P Wang, H Li, ... Cancer research 82 (7), 1340-1352, 2022 | 12 | 2022 |
| Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells MB Almejún, M Borge, A Colado, EE Elías, E Podaza, D Risnik, ... haematologica 102 (7), e257, 2017 | 9 | 2017 |
| Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia D Risnik, A Colado, E Podaza, MB Almejún, EE Elías, RF Bezares, ... Cancer Immunology, Immunotherapy 69, 813-824, 2020 | 7 | 2020 |
| Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia E Podaza, F Palacios, DO Croci, D Risnik, XJ Yan, MB Almejún, A Colado, ... haematologica 105 (9), e465, 2020 | 4 | 2020 |
| Neglected players: Tumor associated neutrophils involvement in chronic lymphocytic leukemia progression EA Podaza, DM Risnik Impact Journals, 2019 | 2 | 2019 |
| Effect of the Btk inhibitors, ibruitinb and AVL-292, and the Syk inhibitor, GS9973, on macrophage-mediated anti-tumor activity of rituximab M Borge, M Belen Almejun, E Podaza, A Colado, D Risnik, ... LEUKEMIA & LYMPHOMA 56, 1-2, 2015 | 2 | 2015 |
| Myeloid cell reprogramming: molecular pathways involved in disease development D Risnik, A Colado, E Podaza Frontiers in Immunology 15, 1414482, 2024 | | 2024 |
| NEO2734, a novel dual bromodomain and histone acetyltransferase inhibitor, in the treatment of colorectal cancer C Kuang, M Cai, D Risnik, F Giles, L Zhang Cancer Research 80 (16_Supplement), 1763-1763, 2020 | | 2020 |
| Effect of intravenous IgM-enriched immunoglobulin (IVIgGM) on in vitro activation of T and B cells from CLL patients and its interactions with other therapeutic agents A Colado, E Enrique Elias, G Raul Cordini, M Vergara Rubio, D Risnik, ... LEUKEMIA & LYMPHOMA 61, 86-87, 2020 | | 2020 |
| In vitro and in vivo expression of the antimicrobial peptide LL-37 in CLL M Giordano, E Podaza, J Yan, D Croci, MB Almejun, F Palacios, D Risnik, ... LEUKEMIA & LYMPHOMA 58, 156-157, 2017 | | 2017 |
